Imugene Ltd
IMU
Company Profile
Business description
Imugene Ltd specializes in a clinical-stage immuno-oncology company. Its product includes HER-Vaxx,PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment being the Research and Development of oncolytic immunotherapies.
Contact
4-6 Bligh Street
Suite 12.01, Level 12
Sydney NSW 2000
AUSSector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2024
Employees
5
Stocks News & Analysis
stocks
What next for these 3 high flying ASX shares?
Wesfarmers, NextDC and WiseTech shares have been flying this year. How do our analysts rate their prospects and valuation?
stocks
11 ASX stocks offering great value right now
These high-quality companies are our top picks for investors wanting to boost their domestic exposure.
stocks
ASX stock gets a moat upgrade
Morningstar analyst Mark Taylor upgrades Seven Group Holdings' moat and fair value rating.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,020.90 | 25.20 | 0.32% |
| CAC 40 | 8,239.99 | 14.20 | 0.17% |
| DAX 40 | 18,869.36 | 152.94 | 0.82% |
| Dow JONES (US) | 39,908.00 | 349.89 | 0.88% |
| FTSE 100 | 8,445.80 | 17.67 | 0.21% |
| HKSE | 19,073.71 | 41.35 | -0.22% |
| NASDAQ | 16,742.39 | 231.21 | 1.40% |
| Nikkei 225 | 38,385.73 | 29.67 | 0.08% |
| NZX 50 Index | 11,542.47 | 16.59 | 0.14% |
| S&P 500 | 5,308.15 | 61.47 | 1.17% |
| S&P/ASX 200 | 7,753.70 | 26.90 | 0.35% |
| SSE Composite Index | 3,145.77 | 2.25 | -0.07% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.05 | 0.00 | 2.17% |
| Pantoro Ltd PNR | 0.08 | 0.00 | 1.25% |
| Core Lithium Ltd CXO | 0.15 | 0.01 | -6.25% |
| Imugene Ltd IMU | 0.07 | 0.00 | -1.41% |
| Renascor Resources Ltd RNU | 0.13 | 0.03 | 30.00% |
| Arafura Rare Earths Ltd ARU | 0.20 | 0.01 | 5.41% |
| South32 Ltd S32 | 3.67 | 0.05 | 1.38% |
| Karoon Energy Ltd KAR | 1.88 | 0.03 | -1.31% |
| Red 5 Ltd RED | 0.47 | 0.01 | -1.05% |
| Medibank Private Ltd MPL | 3.73 | 0.01 | 0.27% |